An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is the most refractory subtype of breast cancer. Immune checkpoint inhibitor (ICI) therapy has made progress in TNBC treatment. PD-L1 expression is a useful biomarker of ICI therapy efficacy. However, tumor-immune microenvironment (TIME) factors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaowei, Su, Wenjia, Tang, Dabei, Jing, Jing, Xiong, Jing, Deng, Yuwei, Liu, Huili, Ma, Wenjie, Liu, Zhaoliang, Zhang, Qingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582543/
https://www.ncbi.nlm.nih.gov/pubmed/34771505
http://dx.doi.org/10.3390/cancers13215342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582543/
https://www.ncbi.nlm.nih.gov/pubmed/34771505
http://dx.doi.org/10.3390/cancers13215342

Ejemplares similares